series-b
Stage
About
AusperBio is a clinical-stage biopharmaceutical company developing antisense oligonucleotide therapeutics primarily targeting hepatitis B virus (HBV) and other diseases such as viral infections, metabolic, genetic, and immune disorders using its proprietary Med-Oligo™ ASO platform.
Explore 浩博医药AusperBio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.